Head Biostatistics & Programming, Ophthalmic Gene Therapy

Initial Therapeutics, Inc.; Malvern (Chester County); On-site; USD 150,000 - 200,000; Full time

Job summary

Initial Therapeutics, Inc. is seeking a Director of Biostatistics & Statistical Programming in Malvern, PA. This leadership role offers the chance to guide biostatistics strategy for pioneering gene therapy projects aimed at treating inherited retinal diseases.

The ideal candidate will possess significant experience in biopharmaceutical development, regulatory submissions, and clinical trial design specific to ophthalmology. Strong leadership and communication skills are essential. This position offers a collaborative environment with a focus on high-quality and timely regulatory deliverables.

Qualifications

• 15+ years of experience in biostatistics/statistical programming.
• Strong record of late-stage clinical development and regulatory submissions.
• Expertise in ophthalmic endpoints and gene therapy clinical development.

Responsibilities

• Lead biostatistics and statistical programming activities.
• Oversee statistical design and analysis for clinical programs.
• Ensure quality and regulatory compliance for programming deliverables.

Skills

Biostatistics expertise

Statistical programming

Leadership in biopharmaceutical development

Clinical trial design

Regulatory submissions

Education

PhD or MS in Biostatistics or related field

Tools

Statistical software packages

Job description

Initial Therapeutics, Inc. is seeking a Director of Biostatistics & Statistical Programming in Malvern, PA. This leadership role offers the chance to guide biostatistics strategy for pioneering gene therapy projects aimed at treating inherited retinal diseases.

The ideal candidate will possess significant experience in biopharmaceutical development, regulatory submissions, and clinical trial design specific to ophthalmology. Strong leadership and communication skills are essential. This position offers a collaborative environment with a focus on high-quality and timely regulatory deliverables.